Dustin Boothe, MD

Intermountain Healthcare
Salt Lake City, UT

Disclosures:

  • Employment: Intermountain Health:Physician:Employee
  • Compensation: Cellectar Biosciences: Advisory Board, Advisory Board Type, Advisory Board Proprietary, Consultant, Travel Expenses, Compensation Payment-End Date: 12/31/2024 ;RadOnc Questions: Consultant, Compensation Payment-End Date: 12/31/2024 ;Novartis: Honoraria, Compensation Payment-End Date: 02/15/2025 ;AllyGPO: Speaker's Bureau, Honoraria, Travel Expenses-End Date: 09/13/2024 ;Prostate Cancer Foundation: Speaker's Bureau, Honoraria, Travel Expenses-End Date: 03/28/2025 ;GE Healthcare: Advisory Board, A
  • Ownership: none
  • Leadership: none

Presentations

Sep 30

3351 - ProstACT Global: A Phase 3 Study of Lutetium (Lu177) Rosopatamab Tetraxetan<sup> </sup>plus Standard of Care vs. Standard of Care Alone in Patients with Metastatic Castration-Resistant Prostate Cancer
Hall F
12:45pm - 02:00pm PT